Is prophylactic embolization of the hepatic falciform artery needed before radioembolization in patients with 99mTc-MAA accumulation in the anterior abdominal wall

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 38, Issue 8, 2011, Pages 1477-1484

  Ahmadzadehfar, Hojjat ^a   Möhlenbruch, Markus ^a   Sabet, Amir ^a   Meyer, Carsten ^a   Muckle, Marianne ^a   Haslerud, Torjan ^a   Wilhelm, Kai ^a   Schild, Hans Heinz ^a   Biersack, Hans Jürgen ^a   Ezziddin, Samer ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

90Y microspheres; 99mTc macroaggregated albumin; Bremsstrahlung; Hepatic falciform artery; Radioembolization; SIRT; SPECT CT

Indexed keywords

MACROSALB TC 99M;

ABDOMINAL PAIN; ABDOMINAL WALL; ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; BIOACCUMULATION; CONTROLLED STUDY; FALCIFORM LIGAMENT; FEMALE; FOLLOW UP; HEPATIC ARTERY; HUMAN; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; RADIOLOGIST; RETROSPECTIVE STUDY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; WHOLE BODY SCINTISCANNING;

ABDOMINAL WALL; ADULT; AGED; AGED, 80 AND OVER; EMBOLIZATION, THERAPEUTIC; FEMALE; HEPATIC ARTERY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RADIATION INJURIES; RETROSPECTIVE STUDIES; TECHNETIUM TC 99M AGGREGATED ALBUMIN;

EID: 80052599582     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-011-1807-z     Document Type: Article

References (21)

1. Ahmadzadehfar H, Biersack HJ, Ezziddin S. Radioembolization of liver tumours with yttrium-90 microspheres. Semin Nucl Med. 2010;40:105-21. doi:10.1053/j.semnuclmed.2009.11.001.
2. Murthy R, Nunez R, Szklaruk J, Erwin W, Madoff DC, Gupta S, et al. Yttrium-90 microsphere therapy for hepatic malignancy: Devices, indications, technical considerations, and potential complications. Radiographics. 2005;25 Suppl 1:S41-55. doi:10.1148/ rg.25si055515. (Pubitemid 41686061)
3. Salem R, Thurston KG. Radioembolization with 90Yttrium microspheres: A state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations. J Vasc Interv Radiol. 2006;17:1251-78. doi:10.1097/ 01.RVI.0000233785.75257.9A. (Pubitemid 44259009)
4. Kennedy A, Nag S, Salem R, Murthy R, McEwan AJ, Nutting C, et al. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: A consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys. 2007;68:13-23. doi:10.1016/j.ijrobp.2006.11.060. (Pubitemid 46589861)
5. Leung TW, Lau WY, Ho SK, Ward SC, Chow JH, Chan MS, et al. Radiation pneumonitis after selective internal radiation treatment with intraarterial 90yttrium-microspheres for inoperable hepatic tumors. Int J Radiat Oncol Biol Phys. 1995;33:919-24..
6. Murthy R, Brown DB, Salem R, Meranze SG, Coldwell DM, Krishnan S, et al. Gastrointestinal complications associated with hepatic arterial yttrium-90 microsphere therapy. J Vasc Interv Radiol. 2007;18:553-62. doi:10.1016/j.jvir. 2007.02.002. (Pubitemid 46566540)
7. Carretero C, Munoz-Navas M, Betes M, Angos R, Subtil JC, Fernandez-Urien I, et al. Gastroduodenal injury after radioembolization of hepatic tumors. Am J Gastroenterol. 2007;102:1216-20. doi:10.1111/j.1572-0241.2007.01172.x. (Pubitemid 46802020)
8. Salem R, Parikh P, Atassi B, Lewandowski RJ, Ryu RK, Sato KT, et al. Incidence of radiation pneumonitis after hepatic intra-arterial radiotherapy with yttrium-90 microspheres assuming uniform lung distribution. Am J Clin Oncol. 2008;31:431-8. doi:10.1097/ COC.0b013e318168ef65.
9. Yip D, Allen R, Ashton C, Jain S. Radiation-induced ulceration of the stomach secondary to hepatic embolization with radioactive yttrium microspheres in the treatment of metastatic colon cancer. J Gastroenterol Hepatol. 2004;19:347-9. (Pubitemid 38338751)
10. Atassi B, Bangash AK, Lewandowski RJ, Ibrahim S, Kulik L, Mulcahy MF, et al. Biliary sequelae following radioembolization with Yttrium-90 microspheres. J Vasc Interv Radiol. 2008;19:691-7. doi:10.1016/j.jvir.2008.01.003.
11. Riaz A, Lewandowski RJ, Kulik LM, Mulcahy MF, Sato KT, Ryu RK, et al. Complications following radioembolization with yttrium-90 microspheres: A comprehensive literature review. J Vasc Interv Radiol. 2009;20:1121-30. doi:10.1016/j. jvir.2009.05.030.
12. Ahmadzadehfar H, Sabet A, Biermann K, Muckle M, Brockmann H, Kuhl C, et al. The significance of 99mTc-MAA SPECT/CT liver perfusion imaging in treatment planning for 90Ymicrosphere selective internal radiation treatment. J Nucl Med. 2010;51:1206-12. doi:10.2967/jnumed.109.074559.
13. Hamami ME, Poeppel TD, Muller S, Heusner T, Bockisch A, Hilgard P, et al. SPECT/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer. J Nucl Med. 2009;50:688-92. doi:10.2967/jnumed.108. 058347.
14. Baba Y, Miyazono N, Ueno K, Kanetsuki I, Nishi H, Inoue H, et al. Hepatic falciform artery. Angiographic findings in 25 patients. Acta Radiol. 2000;41:329-33.
15. Williams DM, Cho KJ, Ensminger WD, Ziessman HA, Gyves JW. Hepatic falciform artery: Anatomy, angiographic appearance, and clinical significance. Radiology. 1985;156:339-40. (Pubitemid 15029760)
16. Gibo M, Hasuo K, Inoue A, Miura N, Murata S. Hepatic falciform artery: Angiographic observations and significance. Abdom Imaging. 2001;26:515-9. (Pubitemid 32803625)
17. Song SY, Chung JW, Lim HG, Park JH. Nonhepatic arteries originating from the hepatic arteries: Angiographic analysis in 250 patients. J Vasc Interv Radiol. 2006;17:461-9. doi:10.1097/01. rvi.0000202718.16416.18. (Pubitemid 44270929)
18. Leong QM, Lai HK, Lo RG, Teo TK, Goh A, Chow PK. Radiation dermatitis following radioembolization for hepatocellular carcinoma: A case for prophylactic embolization of a patent falciform artery. J Vasc Interv Radiol. 2009;20:833-6. doi:10.1016/j.jvir.2009.03.011.
19. Chernyak I, Bester L, Freund J, Richardson M. Anterior abdominal wall uptake in intrahepatic arterial brachytherapy with yttrium-90 sir spheres for hepatic malignancy. Clin Nucl Med. 2008;33:677-80. doi:10.1097/RLU. 0b013e318184b44f.
20. Liu DM, Salem R, Bui JT, Courtney A, Barakat O, Sergie Z, et al. Angiographic considerations in patients undergoing liver-directed therapy. J Vasc Interv Radiol. 2005;16:911-35. doi:10.1097/01. RVI.0000164324.79242.B2.
21. Kao YH, Tan AE, Khoo LS, Lo RH, Chow PK, Goh AS. Hepatic falciform ligament Tc-99 m-macroaggregated albumin activity on SPECT/CT prior to Yttrium-90 microsphere radioembolization: Prophylactic measures to prevent non-target microsphere localization via patent hepatic falciform arteries. Ann Nucl Med. 2011. doi:10.1007/s12149-010-0464-9.